Peter Alping

PhD Student, Medical Student

Peter Alping

Hi!

My name is Peter and I'm a PhD student at the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. My research is mainly focused around pharmacoepidemiological studies of disease modifying drugs for multiple sclerosis, with a special interest in rituximab.

Publications

  1. P. Alping, T. Frisell, L. Novakova, P. Islam-Jakobsson, J. Salzer, A. Bjorck, M. Axelsson, C. Malmestrom, K. Fink, J. Lycke, A. Svenningsson and F. Piehl, “Rituximab versus fingolimod after natalizumab in multiple sclerosis patients,” Ann Neurol, vol. 79, no. 6, pp. 950-8, 2016.
    [BibTeX]

    @article{Alping2016,
    	author = {Alping, P. and Frisell, T. and Novakova, L. and Islam-Jakobsson, P. and Salzer, J. and Bjorck, A. and Axelsson, M. and Malmestrom, C. and Fink, K. and Lycke, J. and Svenningsson, A. and Piehl, F.},
    	title = {Rituximab versus fingolimod after natalizumab in multiple sclerosis patients},
    	journal = {Ann Neurol},
    	year = {2016},
    	volume = {79},
    	number = {6},
    	pages = {950--8},
    	doi = {http://doi.org/10.1002/ana.24651}
    	}
    				
  2. J. Salzer, R. Svenningsson, P. Alping, L. Novakova, A. Bjorck, K. Fink, P. Islam-Jakobsson, C. Malmestrom, M. Axelsson, M. Vagberg, P. Sundstrom, J. Lycke, F. Piehl and A. Svenningsson, “Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy,” Neurology, 2016.
    [BibTeX]

    @article{Salzer2016,
    	author = {Salzer, J. and Svenningsson, R. and Alping, P. and Novakova, L. and Bjorck, A. and Fink, K. and Islam-Jakobsson, P. and Malmestrom, C. and Axelsson, M. and Vagberg, M. and Sundstrom, P. and Lycke, J. and Piehl, F. and Svenningsson, A.},
    	title = {Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy},
    	journal = {Neurology},
    	year = {2016},
    	doi = {http://doi.org/10.1212/wnl.0000000000003331}
    				}
    				

Peter Alping, PhD Student, Medical Student

Department of Clinical Neuroscience

Karolinska Institutet, Stockholm

E-mail: peter.alping@ki.se